Pharma

Sun gets USFDA nod for generic heart disease drug

eHEALTH BureauDrug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.The company’s US subsidiary has bagged a tentative approval for its abbreviated new drug application (ANDA) to market a generic version of IPR Pharmaceutical’s Crestor tablets in strengths of 5 mg, 10 mg, 20 mg and 40 mg, Sun Pharma said in a statement.Crestor has annual sales of nearly US $3.4 billion in the US market. The generic Rosuvastatin tablets contain Rosuvastatin Calcium in strengths of 5 mg, 10 mg, 20 mg and 40 mg, it said.The tablets are indicated in patients suffering with heart diseases like pertriglyceridemia and patients with homozygous familial hypercholesterolemia.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

X
Subscribe Newsletter
To Top